Germline whole genome sequencing in pediatric oncology in Denmark: Practitioner perspectives
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Germline whole genome sequencing in pediatric oncology in Denmark : Practitioner perspectives. / Byrjalsen, Anna; Stoltze, Ulrik Kristoffer; Castor, Anders; Wahlberg, Ayo.
In: Molecular Genetics & Genomic Medicine, Vol. 8, No. 8, e1276, 2020.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Germline whole genome sequencing in pediatric oncology in Denmark
T2 - Practitioner perspectives
AU - Byrjalsen, Anna
AU - Stoltze, Ulrik Kristoffer
AU - Castor, Anders
AU - Wahlberg, Ayo
PY - 2020
Y1 - 2020
N2 - BackgroundWith the implementation of a research project providing whole genome sequencing (WGS) to all pediatric cancer patients in Denmark (2016–2019), we sought to investigate healthcare professionals' views on WGS as it was actively being implemented in pediatric oncology.MethodsSemistructured interviews were carried out with pediatric oncologists, clinical geneticists, and research coordinating nurses (N = 17), followed by content analysis of transcribed interviews. Interviews were supplemented by ethnographic observations on Danish pediatric oncology wards. Additionally, questionnaires were distributed to healthcare professionals concerning when they found it appropriate to approach families regarding WGS. The response rate was 74%.ResultsHealthcare professionals see imbalances in doctor–patient relationship, especially the double role doctors have as clinicians and researchers. Some were concerned that it might not be possible to obtain meaningful informed consent from all families following diagnosis. Still, 94% of respondents found it acceptable to approach families during the first 4 weeks from the child's diagnosis. Views on the utility of WGS, treatment adaptation, and surveillance differed among interviewees.ConclusionOverall, healthcare professionals see dilemmas arising from WGS in the pediatric oncology clinic, and some advocate for further educational sessions with families and healthcare professionals. Despite concerns, healthcare professionals overwhelmingly supported early approach of families regarding WGS. Interviewees disagree on the benefits of surveillance based on genetic findings.
AB - BackgroundWith the implementation of a research project providing whole genome sequencing (WGS) to all pediatric cancer patients in Denmark (2016–2019), we sought to investigate healthcare professionals' views on WGS as it was actively being implemented in pediatric oncology.MethodsSemistructured interviews were carried out with pediatric oncologists, clinical geneticists, and research coordinating nurses (N = 17), followed by content analysis of transcribed interviews. Interviews were supplemented by ethnographic observations on Danish pediatric oncology wards. Additionally, questionnaires were distributed to healthcare professionals concerning when they found it appropriate to approach families regarding WGS. The response rate was 74%.ResultsHealthcare professionals see imbalances in doctor–patient relationship, especially the double role doctors have as clinicians and researchers. Some were concerned that it might not be possible to obtain meaningful informed consent from all families following diagnosis. Still, 94% of respondents found it acceptable to approach families during the first 4 weeks from the child's diagnosis. Views on the utility of WGS, treatment adaptation, and surveillance differed among interviewees.ConclusionOverall, healthcare professionals see dilemmas arising from WGS in the pediatric oncology clinic, and some advocate for further educational sessions with families and healthcare professionals. Despite concerns, healthcare professionals overwhelmingly supported early approach of families regarding WGS. Interviewees disagree on the benefits of surveillance based on genetic findings.
KW - Faculty of Social Sciences
KW - clinical genetics
KW - ethics
KW - pediatric oncology
KW - practitioner perspectives
KW - whole genome sequencing
U2 - 10.1002/mgg3.1276
DO - 10.1002/mgg3.1276
M3 - Journal article
C2 - 32500610
VL - 8
JO - Molecular genetics & genomic medicine
JF - Molecular genetics & genomic medicine
SN - 2324-9269
IS - 8
M1 - e1276
ER -
ID: 242461002